Source BioScience Launches Intelligent GenomeCUBE Search Engine
Source BioScience, the international laboratory services and products business, has launched an updated version of its GenomeCUBE search engine, an intelligent and powerful clone, antibody and protein products search and buying tool, which gives researchers easy access to millions of products, as well as Source BioScience’s scientific and technical support services.
Users can enter free text in GenomeCUBE, which interrogates public databases as well as Source BioScience’s own stores of clone libraries and individual clone sets, associated antibodies and kits. The tool also automatically provides a separate list, based on the results, for appropriate antibodies, reagents and kits. Searches can be based on clone identity, accession or other pertinent search terms such as species or cluster. The system now also includes protein databases, to identify gene related antibodies, reagents and kits all in one place.
The search engine enables researchers to access reference content on each of the products, including ‘real-time’ annotated information from multiple public databases. Users can purchase all products they require directly through GenomeCUBE, eliminating the need to search the internet for various providers.
Dr Nick Ash, CEO of Source BioScience, commented: “We have made a significant investment in developing the new infrastructure and search capabilities of GenomeCUBE. The tool now offers users an easier pathway from search to checkout and payment. Using GenomeCUBE researchers can access the information they need, the associated products they may require and proceed to purchase this in as few as three clicks. We believe the market needs a search engine of this type, to enable researchers to access millions of clones, hundreds of thousands of antibodies and the ability to purchase the reagents and kits from one source.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance